Authors:
SINICROPE FA
RODDEY G
LEMOINE M
RUAN S
STEPHENS LC
FRAZIER ML
SHEN Y
ZHANG W
Citation: Fa. Sinicrope et al., LOSS OF P21(WAF1 CIP1) PROTEIN EXPRESSION ACCOMPANIES PROGRESSION OF SPORADIC COLORECTAL NEOPLASMS BUT NOT HEREDITARY NONPOLYPOSIS COLORECTAL CANCERS/, Clinical cancer research, 4(5), 1998, pp. 1251-1261
Authors:
SINICROPE FA
RODDEY G
LEMOINE M
RUAN S
STEPHENS LC
FRAZIER ML
SHEN Y
ZHANG W
Citation: Fa. Sinicrope et al., LOSS OF P21(WAF1 CIP1) PROTEIN EXPRESSION ACCOMPANIES PROGRESSION OF SPORADIC COLORECTAL NEOPLASMS BUT NOT HEREDITARY NONPOLYPOSIS COLORECTAL CANCERS/, Clinical cancer research, 4(5), 1998, pp. 1251-1261
Citation: M. Lemoine et Fa. Sinicrope, PATTERN OF CELL-CYCLE INHIBITION IN SW480 COLON-CARCINOMA CELLS FOLLOWING EXPOSURE TO SULINDAC SULFIDE AND 5-FLUOROURACIL, Gastroenterology, 114(4), 1998, pp. 2613-2613
Authors:
SINICROPE FA
RODDEY G
MCDONNELL TJ
SHEN Y
CLEARY KR
STEPHENS LC
Citation: Fa. Sinicrope et al., INCREASED APOPTOSIS ACCOMPANIES NEOPLASTIC DEVELOPMENT IN THE HUMAN COLORECTUM, Clinical cancer research, 2(12), 1996, pp. 1999-2006
Authors:
SINICROPE FA
EVANS DB
LEACH SD
CLEARY KR
FENOGLIO CJ
LEE JJ
ABBRUZZESE JL
Citation: Fa. Sinicrope et al., BCL-2 AND P53 EXPRESSION IN RESECTABLE PANCREATIC ADENOCARCINOMAS - ASSOCIATION WITH CLINICAL OUTCOME, Clinical cancer research, 2(12), 1996, pp. 2015-2022
Citation: Fa. Sinicrope et al., PHASE-I TRIAL OF SULINDAC PLUS 5-FLUOROURACIL AND LEVAMISOLE - POTENTIAL ADJUVANT THERAPY FOR COLON-CARCINOMA, Clinical cancer research, 2(1), 1996, pp. 37-41
Citation: Ld. Roubein et al., INTEROBSERVER VARIABILITY IN ENDOSCOPIC ULTRASONOGRAPHY - A PROSPECTIVE EVALUATION, Gastrointestinal endoscopy, 44(5), 1996, pp. 573-577
Authors:
RODDEY G
STEPHENS LC
ZHANG W
SELLIN J
SHEN Y
SINICROPE FA
Citation: G. Roddey et al., EXPRESSION OF P21(WAF1 CIP1) AND P53 GENES DURING HUMAN COLORECTAL TUMORIGENESIS - ASSOCIATION WITH APOPTOSIS/, Gastroenterology, 110(4), 1996, pp. 584-584
Authors:
SINICROPE FA
RODDEY G
STEPHENS LC
MEYN RE
GLOBER G
SHEN Y
PAZDUR R
Citation: Fa. Sinicrope et al., EVALUATION OF BCL-2 AND P53 ONCOGENES AND APOPTOTIC RATES AS PREDICTORS OF CHEMOTHERAPY RESPONSE IN COLORECTAL-CANCER, Gastroenterology, 110(4), 1996, pp. 594-594
Authors:
SINICROPE FA
RODDEY G
MCDONNELL TJ
SHEN Y
STEPHENS LC
Citation: Fa. Sinicrope et al., PROGRESSIVE INCREASE IN APOPTOTIC RATES DURING COLORECTAL TUMOR PROGRESSION, Gastroenterology, 110(4), 1996, pp. 595-595
Authors:
SINICROPE FA
LEACH SD
CLEARY KR
LEE JJ
EVANS DB
ABBRUZZESE JL
Citation: Fa. Sinicrope et al., PROGNOSTIC VALUE OF THE BCL-2 PROTOONCOGENE IN RESECTABLE PANCREATIC-CANCER, Gastroenterology, 110(4), 1996, pp. 595-595
Authors:
ALSABBAGH R
SINICROPE FA
SELLIN JH
SHEN Y
ROUBEIN L
Citation: R. Alsabbagh et al., EVALUATION OF SHORT-CHAIN FATTY-ACID ENEMAS - TREATMENT OF RADIATION PROCTITIS, The American journal of gastroenterology, 91(9), 1996, pp. 1814-1816
Citation: Fa. Sinicrope et al., PROGNOSTIC VALUE OF BCL-2 ONCOPROTEIN EXPRESSION IN STAGE-II COLON-CARCINOMA, Clinical cancer research, 1(10), 1995, pp. 1103-1110
Citation: Fa. Sinicrope et Sm. Sugarman, ROLE OF ADJUVANT THERAPY IN SURGICALLY RESECTED COLORECTAL-CARCINOMA, Gastroenterology, 109(3), 1995, pp. 984-993
Citation: Fa. Sinicrope et al., PROGNOSTIC VALUE OF BCL-2 AND P53 ONCOGENE EXPRESSION IN LYMPH NODE-NEGATIVE COLON-CANCER, Gastroenterology, 108(4), 1995, pp. 538-538
Citation: Fa. Sinicrope et al., SULINDAC PLUS 5-FLUOROURACIL AND LEVAMISOLE - POTENTIAL ADJUVANT TREATMENT FOR COLON-CANCER, Gastroenterology, 108(4), 1995, pp. 539-539
Citation: Fa. Sinicrope et al., EXPRESSION OF THE BCL-2 PROTOONCOGENE IN HUMAN COLORECTAL-CARCINOMA, Gastroenterology, 106(4), 1994, pp. 10000442-10000442
Authors:
SINICROPE FA
HART J
BRASITUS TA
MICHELASSI F
LEE JJ
SAFA AR
Citation: Fa. Sinicrope et al., RELATIONSHIP OF P-GLYCOPROTEIN AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN HUMAN COLON-CARCINOMA TO LOCAL INVASION, DNA-PLOIDY, AND DISEASE RELAPSE, Cancer, 74(11), 1994, pp. 2908-2917